DE69104083D1 - Neue Antiulcus-Substanz. - Google Patents

Neue Antiulcus-Substanz.

Info

Publication number
DE69104083D1
DE69104083D1 DE69104083T DE69104083T DE69104083D1 DE 69104083 D1 DE69104083 D1 DE 69104083D1 DE 69104083 T DE69104083 T DE 69104083T DE 69104083 T DE69104083 T DE 69104083T DE 69104083 D1 DE69104083 D1 DE 69104083D1
Authority
DE
Germany
Prior art keywords
antiulcus
substance
new
preparation
cyclohepten
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69104083T
Other languages
English (en)
Other versions
DE69104083T2 (de
Inventor
Kiyokazu Murakami
Susumu Yokura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tokyo Pharmaceuticals Inc
Original Assignee
Tokyo Tanabe Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokyo Tanabe Co Ltd filed Critical Tokyo Tanabe Co Ltd
Publication of DE69104083D1 publication Critical patent/DE69104083D1/de
Application granted granted Critical
Publication of DE69104083T2 publication Critical patent/DE69104083T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/32—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by aldehydo- or ketonic radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125—Camphor; Nuclear substituted derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78—Separation; Purification; Stabilisation; Use of additives
    • C07C45/79—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/717—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups a keto group being part of a seven- to twelve-membered ring
DE69104083T 1990-02-22 1991-02-21 Neue Antiulcus-Substanz. Expired - Fee Related DE69104083T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3966390 1990-02-22
JP2325333A JPH0745426B2 (ja) 1990-02-22 1990-11-29 新規抗潰瘍物質

Publications (2)

Publication Number Publication Date
DE69104083D1 true DE69104083D1 (de) 1994-10-27
DE69104083T2 DE69104083T2 (de) 1995-06-22

Family

ID=26379045

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69104083T Expired - Fee Related DE69104083T2 (de) 1990-02-22 1991-02-21 Neue Antiulcus-Substanz.

Country Status (8)

Country Link
EP (1) EP0443848B1 (de)
JP (1) JPH0745426B2 (de)
KR (1) KR0169492B1 (de)
AT (1) ATE111883T1 (de)
AU (1) AU633402B2 (de)
DE (1) DE69104083T2 (de)
DK (1) DK0443848T3 (de)
ES (1) ES2060293T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2076362A1 (en) * 1991-08-21 1993-02-22 Susumu Yokura Saishin n derivatives, process for preparing same and untiulcer agents containing same
USRE37781E1 (en) 1991-10-11 2002-07-02 Dupont Pharmaceuticals Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
US5610294A (en) 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
US5616578A (en) * 1993-08-26 1997-04-01 The Dupont Merck Pharmaceutical Company Method of treating human immunodeficiency virus infection using a cyclic protease inhibitor in combination with a reverse transcriptase inhibitor
CA2212381A1 (en) * 1995-04-12 1996-10-17 Masao Yajima 4-amino-5-oxy-2,6,6-trimethyl-2-cycloheptene compounds
US6313110B1 (en) 1999-06-02 2001-11-06 Dupont Pharmaceuticals Company Substituted 2H-1,3-diazapin-2-one useful as an HIV protease inhibitor
US6737087B2 (en) * 2001-03-13 2004-05-18 Sung-jin Kim Composition containing Asiasari Radix extracts for protecting brain cells and improving memory
KR20030012002A (ko) * 2001-07-30 2003-02-12 진양제약주식회사 세신엑스 연질캅셀
KR100462788B1 (ko) 2001-11-06 2004-12-20 김성진 천초 추출물을 함유하는 뇌세포 보호 및 기억력 증진용조성물
JP4973210B2 (ja) * 2006-11-14 2012-07-11 東亞合成株式会社 新規合成方法
JP6454217B2 (ja) * 2014-05-13 2019-01-16 積水化学工業株式会社 変性ジアルキルアミノ安息香酸系化合物、変性チオキサントン誘導体、光硬化性樹脂組成物、液晶表示素子用シール剤、上下導通材料、及び、液晶表示素子

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749681A (en) * 1986-05-22 1988-06-07 International Flavors & Fragrances Inc. Polyalkyl-substituted oxocycloheptane derivatives, organoleptic uses thereof and processes for preparing same

Also Published As

Publication number Publication date
AU7125991A (en) 1991-08-29
ATE111883T1 (de) 1994-10-15
KR910021361A (ko) 1991-12-20
ES2060293T3 (es) 1994-11-16
EP0443848B1 (de) 1994-09-21
JPH0745426B2 (ja) 1995-05-17
DK0443848T3 (da) 1994-10-17
JPH03275640A (ja) 1991-12-06
KR0169492B1 (ko) 1999-03-20
AU633402B2 (en) 1993-01-28
EP0443848A1 (de) 1991-08-28
DE69104083T2 (de) 1995-06-22

Similar Documents

Publication Publication Date Title
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
ITRM910696A0 (it) Composizioni farmaceutiche per l'applicazione per via nasale.
IL57020A (en) Carbazolyl-(4)-oxypropanolamine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
MX9102353A (es) N,o-sulfados de heparosanos, su procedimiento de preparacion y las composiciones farmaceuticas que contienen.
IL99030A0 (en) 1,4-dihydropyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
MX24839A (es) 3-arilcarbonil-1-aminoalquilo-1h-indoles, proceso para su preparacion y composicion farmaceutica quelos contiene.
DE69104083D1 (de) Neue Antiulcus-Substanz.
DE3887068D1 (de) 2,2-Dimethylchromenderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
DE69012650D1 (de) Piperidinderivat, Verfahren zur Herstellung davon und dieses enthaltende pharmazeutische Zusammensetzung.
DE2961609D1 (en) Sila-substituted 1,4-dihydropyridine derivatives, processes for their preparation, pharmaceutical compositions and process for their preparation
DE3168248D1 (en) Wound healing compositions
DE68920896D1 (de) N2-(1-Carboxy-3-phenylpropyl)-L-lysinderivate und Verfahren für die Herstellung von Lysinopril mit Hilfe dieser Verbindung.
HUT50787A (en) Process for producing pharmaceutical compositions comprising 4-aryl-4-piperidine-, pyrrolidine- or hexahydroazepincarbinol derivatives or heterocyclic analogs thereof as active ingredient and process for producing the new compounds
IT1241631B (it) "n,n'-ditrimetossibenzoilpiperazine 2-sostituite, procedimento per la loro preparazione e composizioni terapeutiche che le contengono
ATE5256T1 (de) Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
IL95210A0 (en) 14,17alpha-etheno-and-ethanoestratrienes,process for the preparation thereof and pharmaceutical compositions containing the same
DE69016592T2 (de) 4-Amidino-Chroman und 4-Amidino-Pyrano(3,2-c)pyridinderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
DE59309355D1 (de) Neue Phospholipidderivate
SE9004169D0 (sv) Anvaendning av farmaceutiska och kosmetiska kompositioner, innehaallande 1,8-dihydroxi-10-fenyl-9-antron som verksam bestaandsdel
ATE106883T1 (de) Azelastin-embonat, verfahren zu seiner herstellung und pharmazeutische zubereitungen, die als wirkstoff azelastin-embonat enthalten.
EP0348664A3 (de) Monoacetoacetine enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Tumoren
FR2652086B1 (fr) Compose nouveau d'origine vegetale, derive de l'acide cafeique, l'oraposide; composition a usage therapeutique et composition dermato-cosmetique le contenant.
DE3888697T2 (de) 2,3-thiomorpholinedion-2-oxim-derivate, arzneimittelzusammensetzungen und verfahren zur herstellung.
FR2673944B1 (fr) Derives de l'1,8-naphtalimide, leur procede de preparation et les compositions pharmaceutiques les contenant.
ATE145647T1 (de) Gem-diphosphonsäure-nitrosocarbamoylderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zubereitungen

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MITSUBISHI-TOKYO PHARMACEUTICALS, INC., TOKIO, JP

8339 Ceased/non-payment of the annual fee